Evidence map›Paper›PMID 25531652›Full record

ArticlePloS one2014

Live cell interferometry quantifies dynamics of biomass partitioning during cytokinesis.

Thomas A Zangle, Michael A Teitell, Jason Reed

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Tracking of lineage massLab on a chip · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Thomas A ZangleDepartment of Bioengineering, University of California Los Angeles (UCLA), Los Angeles, California, United States of America; Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States of America.
Michael A TeitellDepartment of Bioengineering, University of California Los Angeles (UCLA), Los Angeles, California, United States of America; Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States of America; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America; California NanoSystems Institute, UCLA, Los Angeles, California, United States of America; Broad Stem Cell Research Center, UCLA, Los Angeles, California, United States of America; Molecular Biology Institute, UCLA, Los Angeles, California, United States of America.
Jason ReedDepartment of Physics, Virginia Commonwealth University (VCU), Richmond, Virginia, United States of America; VCU Massey Cancer Center, Richmond, Virginia, United States of America.
Broad Center · USUniversity of California, Los Angeles · USVirginia Cancer Institute · US

Funding

Human Embryonic Stem Cell CoreP01GM081621 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GALIC, ZORAN · 2008 to 2012
$9.3M
RNA trafficking in mitochondriaR01GM073981 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Carla M Koehler, MICHAEL A TEITELL · 2006 to 2026
$5.1M
TCL1 ONCOGENE IN B LYMPHOCYTE DEVELOPMENT AND NEOPLASIAR01CA090571 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TEITELL, MICHAEL A · 2002 to 2015
$3.8M
(PQD5) Mass Profiling Melanoma Responses to Improve Therapy Choices and PrognosisR01CA185189 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI REED, JASON C, TEITELL, MICHAEL A · 2014 to 2017
$1.9M
A Fourth Outcome: DNA Damage and the Differentiation of B CellsR01CA156674 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TEITELL, MICHAEL A · 2011 to 2015
$1.5M
Nanotechnologies for Determining Gene Expression Patterns from Single CellsR01GM094388 · NIGMS · VIRGINIA COMMONWEALTH UNIVERSITY · PI REED, JASON C · 2010 to 2013
$1.3M
Live Cell Interferometry for Quantifying Mass Transport in CancerK25CA157940 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ZANGLE, THOMAS ANDREW · 2012 to 2014
$354k
NCI NIH HHS K25 CA157940NCI NIH HHS K25CA157940NCI NIH HHS R01 CA090571NCI NIH HHS R01 CA156674NCI NIH HHS R01CA156674NCI NIH HHS R01 CA185189NCI NIH HHS R01CA185189NCI NIH HHS R01CA90571NIGMS NIH HHS P01 GM081621NIGMS NIH HHS P01GM081621NIGMS NIH HHS R01 GM073981NIGMS NIH HHS R01GM073981NIGMS NIH HHS R01 GM094388NIGMS NIH HHS R01GM094388
6 · The paper itself

Abstract

The equal partitioning of cell mass between daughters is the usual and expected outcome of cytokinesis for self-renewing cells. However, most studies of partitioning during cell division have focused on daughter cell shape symmetry or segregation of chromosomes. Here, we use live cell interferometry (LCI) to quantify the partitioning of daughter cell mass during and following cytokinesis. We use adherent and non-adherent mouse fibroblast and mouse and human lymphocyte cell lines as models and show that, on average, mass asymmetries present at the time of cleavage furrow formation persist through cytokinesis. The addition of multiple cytoskeleton-disrupting agents leads to increased asymmetry in mass partitioning which suggests the absence of active mass partitioning mechanisms after cleavage furrow positioning.

Indexed as

BiomassAnimalsCells, CulturedCell ShapeCell TrackingCytokinesisCytoskeletonFibroblastsHumansInterferometryLymphocytesMiceMicrotubulesMultiple MyelomaSpindle ApparatusTubulin ModulatorsTubulin Modulators

Identifiers

PMID25531652
PMCPMC4274116
OpenAlexW2028868547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.